Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Propenal, 3-(2-methyl-5-pyrimidinyl)- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

393177-83-8

Post Buying Request

393177-83-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

393177-83-8 Usage

General Description

2-Propenal, 3-(2-methyl-5-pyrimidinyl)- (9CI) is a chemical compound with the molecular formula C7H7N3O. It is a derivative of 2-propenal and contains a pyrimidine ring with a methyl substituent. This chemical is used in various applications, such as in the synthesis of pharmaceutical drugs and agrochemicals. It may also have potential uses in research and development for new materials and chemical processes. However, due to its potential for toxicity and environmental impact, careful handling and proper disposal methods are important in working with this chemical.

Check Digit Verification of cas no

The CAS Registry Mumber 393177-83-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,3,1,7 and 7 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 393177-83:
(8*3)+(7*9)+(6*3)+(5*1)+(4*7)+(3*7)+(2*8)+(1*3)=178
178 % 10 = 8
So 393177-83-8 is a valid CAS Registry Number.

393177-83-8Downstream Products

393177-83-8Relevant articles and documents

Alpha v integrin receptor antagonists

-

, (2008/06/13)

The present invention relates to novel chain-fluorinated alkanoic acid derivatives thereof, their synthesis, and their use as αv integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin recep

αv integrin receptor antagonists

-

, (2008/06/13)

The present invention relates to novel nonanoic acid derivatives, their synthesis, and their use as αv integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors αvβ3 and αvβ5 and are

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 393177-83-8